An alternative splicing variant in CLCN7-/- mice prevents osteopetrosis but not neural and retinal degeneration

Veterinary Pathology

Volumn 48, Issue 3, 2011, Pages 663-675

  Rajan, I ^a   Read, R ^a   Small, D L ^a   Perrard, J ^a   Vogel, Peter ^a  

^a LEXICON PHARMACEUTICALS INC   (United States)

Author keywords

chloride channel; lysosomal storage disease; neurodegeneration; osteopetrosis; retinopathy

Indexed keywords

CHLORIDE CHANNEL; CLCN7 PROTEIN, MOUSE;

ALBERS SCHOENBERG DISEASE; ALTERNATIVE RNA SPLICING; ANIMAL; ARTICLE; BONE DENSITY; DEGENERATIVE DISEASE; GENETIC VARIABILITY; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; RETINA DEGENERATION;

ALTERNATIVE SPLICING; ANIMALS; BONE DENSITY; CHLORIDE CHANNELS; GENETIC VARIATION; MICE; MICE, KNOCKOUT; NEURODEGENERATIVE DISEASES; OSTEOPETROSIS; RETINAL DEGENERATION;

MURINAE; MUS;

EID: 79955836601     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810370164     Document Type: Article

References (53)

1. Alper SL. Genetic diseases of acid-base transporters. Annu Rev Physiol. 2002;64: 899-923.
2. Alroy J,Castagnaro M,Skutelsky E,Lomakina I. Lectin histochemistry of infantile lysosomal storage disease associated with osteopetrosis. Acta Neuropathol. 1994;87: 594-597.
3. Bahr BA,Bendiske J. The neuropathogenic contributions of lysosomal dysfunction. J Neurochem. 2002;83: 481-489.
4. Balemans W,Van Wesenbeeck L,Van Hul W. A clinical and molecular overview of the human osteopetroses. Calcif Tissue Int. 2005;77: 263-274.
5. Campos-Xavier AB,Saraiva JM,Ribeiro LM,Munnich A,Cormier-Daire V. Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis. Hum Genet. 2003;112: 186-189.
6. Cataldo AM,Paskevich PA,Kominami E,Nixon RA. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci U S A. 1991;88: 10998-11002.
7. Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl). 1990;181: 195-213.
8. Cooper JD,Russell C,Mitchison HM. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis. Biochim Biophys Acta. 2006;1762: 873-889.
9. Del Fattore A,Cappariello A,Teti A. Genetics, pathogenesis and complications of osteopetrosis. Bone. 2008;42: 19-29.
10. Elleder M,Sokolova J,Hrebicek M. Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders. Acta Neuropathol. 1997;93: 379-390.
11. Felbor U,Kessler B,Mothes W,Goebel HH,Ploegh HL,Bronson RT,Olsen BR. Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci U S A. 2002;99: 7883-7888.
12. Frattini A,Pangrazio A,Susani L,Sobacchi C,Mirolo M,Abinun M,Andolina M,Flanagan A,Horwitz EM,Mihci E,Notarangelo LD,Ramenghi U,Teti A,Van Hove J,Vujic D,Young T,Albertini A,Orchard PJ,Vezzoni P,Villa A. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J Bone Miner Res. 2003;18: 1740-1747.
13. Gupta P,Soyombo AA,Atashband A,Wisniewski KE,Shelton JM,Richardson JA,Hammer RE,Hofmann SL. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc Natl Acad Sci U S A. 2001;98: 13566-13571.
14. Haltia M. The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol. 2003;62: 1-13.
15. Haltia M. The neuronal ceroid-lipofuscinoses: from past to present. Biochim Biophys Acta. 2006;1762: 850-856.
16. Ivy GO. Protease inhibitors as a model for NCL disease, with special emphasis on the infantile and adult forms. Am J Med Genet. 1992;42: 555-560.
17. Ivy GO,Kanai S,Ohta M,Smith G,Sato Y,Kobayashi M,Kitani K. Lipofuscin-like substances accumulate rapidly in brain, retina and internal organs with cysteine protease inhibition. Adv Exp Med Biol. 266: 31-45.
18. Ivy GO,Schottler F,Wenzel J,Baudry M,Lynch G. Inhibitors of lysosomal enzymes: accumulation of lipofuscin-like dense bodies in the brain. Science. 1984;226: 985-987.
19. Jalanko A,Braulke T. Neuronal ceroid lipofuscinoses. Biochim Biophys Acta. 2009;1793: 697-709.
20. Jarplid B,Haltia M. An animal model of the infantile type of neuronal ceroid-lipofuscinosis. J Inherit Metab Dis. 1993;16: 274-277.
21. Jentsch TJ,Maritzen T,Zdebik AA. Chloride channel diseases resulting from impaired transepithelial transport or vesicular function. J Clin Invest. 2005;115: 2039-2046.
22. Kasper D,Planells-Cases R,Fuhrmann JC,Scheel O,Zeitz O,Ruether K,Schmitt A,Poet M,Steinfeld R,Schweizer M,Kornak U,Jentsch TJ. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J. 2005;24: 1079-1091.
23. Koike M,Nakanishi H,Saftig P,Ezaki J,Isahara K,Ohsawa Y,Schulz-Schaeffer W,Watanabe T,Waguri S,Kametaka S,Shibata M,Yamamoto K,Kominami E,Peters C,von Figura K,Uchiyama Y. Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci. 2000;20: 6898-6906.
24. Koike M,Shibata M,Waguri S,Yoshimura K,Tanida I,Kominami E,Gotow T,Peters C,von Figura K,Mizushima N,Saftig P,Uchiyama Y. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). Am J Pathol. 2005;167: 1713-1728.
25. Kornak U,Kasper D,Bosl MR,Kaiser E,Schweizer M,Schulz A,Friedrich W,Delling G,Jentsch TJ. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 2001;104: 205-215.
26. Lange PF,Wartosch L,Jentsch TJ,Fuhrmann JC. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature. 2006;440: 220-223.
27. Matsumura M,Ohkuma M,Tsukahara I. Experimental chloroquine retinopathy. Ophthalmic Res. 1986;18: 172-179.
28. Mole SE. The genetic spectrum of human neuronal ceroid-lipofuscinoses. Brain Pathol. 2004;14: 70-76.
29. Nakanishi H,Zhang J,Koike M,Nishioku T,Okamoto Y,Kominami E,von Figura K,Peters C,Yamamoto K,Saftig P,Uchiyama Y. Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice. J Neurosci. 2001;21: 7526-7533.
30. O'Gorman S,Dagenais NA,Qian M,Marchuk Y. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc Natl Acad Sci U S A. 1997;94: 14602-14607.
31. Pivtoraiko VN,Stone SL,Roth KA,Shacka JJ. Oxidative stress and autophagy in the regulation of lysosome-dependent neuron death. Antioxid Redox Signal. 2009;11: 481-496.
32. Pontikis CC,Cella CV,Parihar N,Lim MJ,Chakrabarti S,Mitchison HM,Mobley WC,Rezaie P,Pearce DA,Cooper JD. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation Brain Res. 2004;1023: 231-242.
33. Ruben JB,Morris RJ,Judisch GF. Chorioretinal degeneration in infantile malignant osteopetrosis. Am J Ophthalmol. 1990;110: 1-5.
34. Schaller S,Henriksen K,Sveigaard C,Heegaard AM,Helix N,Stahlhut M,Ovejero MC,Johansen JV,Solberg H,Andersen TL,Hougaard D,Berryman M,Shiodt CB,Sorensen BH,Lichtenberg J,Christophersen P,Foged NT,Delaisse JM,Engsig MT,Karsdal MA. The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation. J Bone Miner Res. 2004;19: 1144-1153.
35. Scimeca JC,Franchi A,Trojani C,Parrinello H,Grosgeorge J,Robert C,Jaillon O,Poirier C,Gaudray P,Carle GF. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone. 2000;26: 207-213.
36. Seehafer SS,Pearce DA. You say lipofuscin, we say ceroid: defining autofluorescent storage material. Neurobiol Aging. 2006;27: 576-588.
37. Shacka JJ,Klocke BJ,Young C,Shibata M,Olney JW,Uchiyama Y,Saftig P,Roth KA. Cathepsin D deficiency induces persistent neurodegeneration in the absence of Bax-dependent apoptosis. J Neurosci. 2007;27: 2081-2090.
38. Siintola E,Partanen S,Stromme P,Haapanen A,Haltia M,Maehlen J,Lehesjoki AE,Tyynela J. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain. 2006;129: 1438-1445.
39. Sobacchi C,Frattini A,Orchard P,Porras O,Tezcan I,Andolina M,Babul-Hirji R,Baric I,Canham N,Chitayat D,Dupuis-Girod S,Ellis I,Etzioni A,Fasth A,Fisher A,Gerritsen B,Gulino V,Horwitz E,Klamroth V,Lanino E,Mirolo M,Musio A,Matthijs G,Nonomaya S,Notarangelo LD,Ochs HD,Superti Furga A,Valiaho J,van Hove JL,Vihinen M,Vujic D,Vezzoni P,Villa A. The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum Mol Genet. 2001;10: 1767-1773.
40. Steward CG. Neurological aspects of osteopetrosis. Neuropathol Appl Neurobiol. 2003;29: 87-97.
41. Stobrawa SM,Breiderhoff T,Takamori S,Engel D,Schweizer M,Zdebik AA,Bosl MR,Ruether K,Jahn H,Draguhn A,Jahn R,Jentsch TJ. Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron. 2001;29: 185-196.
42. Sundelin SP,Terman A. Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells. APMIS. 2002;110: 481-489.
43. Tang CH,Lee JW,Galvez MG,Robillard L,Mole SE,Chapman HA. Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease. Mol Cell Biol. 2006;26: 2309-2316.
44. Thompson DA,Kriss A,Taylor D,Russell-Eggitt I,Hodgkins P,Morgan G,Vellodi A,Gerritsen EJ. Early VEP and ERG evidence of visual dysfunction in autosomal recessive osteopetrosis. Neuropediatrics. 1998;29: 137-144.
45. Tolar J,Teitelbaum SL,Orchard PJ. Osteopetrosis. N Engl J Med. 2004;351: 2839-2849.
46. Tyynela J,Sohar I,Sleat DE,Gin RM,Donnelly RJ,Baumann M,Haltia M,Lobel P. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J. 2000;19: 2786-2792.
47. Van Wesenbeeck L,Van Hul W. Lessons from osteopetrotic mutations in animals: impact on our current understanding of osteoclast biology. Crit Rev Eukaryot Gene Expr. 2005;15: 133-162.
48. Vogel P,Payne BJ,Read R,Lee WS,Gelfman CM,Kornfeld S. Comparative pathology of murine mucolipidosis types II and IIIC. Vet Pathol. 2009;46: 313-324.
49. Waguespack SG,Hui SL,Dimeglio LA,Econs MJ. Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation. J Clin Endocrinol Metab. 2007;92: 771-778.
50. Walker DG. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science. 1975;190: 784-785.
51. Walker DG. Osteopetrosis cured by temporary parabiosis. Science. 1973;180: 875.
52. Wattler S,Kelly M,Nehls M. Construction of gene targeting vectors from lambda KOS genomic libraries. Biotechniques. 1999;26: 1150 1158 1160-1156.
53. Yoshikawa M,Uchida S,Ezaki J,Rai T,Hayama A,Kobayashi K,Kida Y,Noda M,Koike M,Uchiyama Y,Marumo F,Kominami E,Sasaki S. CLC-3 deficiency leads to phenotypes similar to human neuronal ceroid lipofuscinosis. Genes Cells. 2002;7: 597-605.